These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 37554942

  • 1. Histopathological findings affect quantitative values of single photon emission computed tomography in patients with antiresorptive agent-related osteonecrosis of the jaws.
    Okui T, Kobayashi Y, Isomura M, Tsujimoto M, Satoh K, Toyama H.
    Fujita Med J; 2023 Aug; 9(3):186-193. PubMed ID: 37554942
    [Abstract] [Full Text] [Related]

  • 2. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
    Okui T, Kobayashi Y, Tsujimoto M, Satoh K, Toyama H, Matsuo K.
    Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
    [Abstract] [Full Text] [Related]

  • 3. Effect of morphological findings in computed tomography on the quantitative values in single-photon emission computed tomography for patients with antiresorptive agent-related osteonecrosis of the jaw: a cross-sectional study.
    Kobayashi Y, Okui T, Tsujimoto M, Ikeda H, Satoh K, Kanamori D, Fujii N, Toyama H, Matsuo K.
    Ann Nucl Med; 2021 Jul; 35(7):853-860. PubMed ID: 33997910
    [Abstract] [Full Text] [Related]

  • 4. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.
    Hata H, Kitao T, Sato J, Asaka T, Ohga N, Imamachi K, Hirata K, Shiga T, Yamazaki Y, Kitagawa Y.
    Sci Rep; 2020 Jul 09; 10(1):11385. PubMed ID: 32647190
    [Abstract] [Full Text] [Related]

  • 5. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
    An YS, Park DY, Min BH, Lee SJ, Yoon JK.
    BMC Med Imaging; 2021 Mar 26; 21(1):60. PubMed ID: 33771130
    [Abstract] [Full Text] [Related]

  • 6. Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
    Yamamoto Y, Mitsunaga S, Horikawa A, Hino A, Kurihara H.
    Ann Nucl Med; 2020 Jan 26; 34(1):74-79. PubMed ID: 31705367
    [Abstract] [Full Text] [Related]

  • 7. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
    Toshima H, Ogura I.
    Dentomaxillofac Radiol; 2020 Dec 01; 49(8):20200043. PubMed ID: 32491931
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
    Moridera K, Kitajima K, Yoshikawa K, Takaoka K, Tsuchitani T, Noguchi K, Kishimoto H, Yamakado K.
    Jpn J Radiol; 2022 May 01; 40(5):492-499. PubMed ID: 34851501
    [Abstract] [Full Text] [Related]

  • 9. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H, Kobashi Y, Yamazoe S, Munetomo Y, Mogami T, Nomura T.
    Dentomaxillofac Radiol; 2018 May 01; 47(4):20170323. PubMed ID: 29365278
    [Abstract] [Full Text] [Related]

  • 10. Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
    Assaf AT, Zrnc TA, Remus CC, Adam G, Zustin J, Heiland M, Friedrich RE, Derlin T.
    J Craniomaxillofac Surg; 2015 Oct 01; 43(8):1461-9. PubMed ID: 26232916
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
    Moridera K, Kitajima K, Yoshikawa K, Takaoka K, Tsuchitani T, Noguchi K, Kishimoto H, Yamakado K.
    Jpn J Radiol; 2023 Jul 01; 41(7):760-767. PubMed ID: 36656541
    [Abstract] [Full Text] [Related]

  • 12. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
    Ogura I, Kobayashi E, Nakahara K, Igarashi K, Haga-Tsujimura M, Toshima H.
    Ann Nucl Med; 2019 Oct 01; 33(10):776-782. PubMed ID: 31342316
    [Abstract] [Full Text] [Related]

  • 13. Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging.
    Miyashita H, Kameyama K, Morita M, Nakagawa T, Nakahara T.
    Dentomaxillofac Radiol; 2019 Dec 01; 48(8):20190208. PubMed ID: 31287720
    [Abstract] [Full Text] [Related]

  • 14. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
    Tezuka Y, Ogura I.
    Dentomaxillofac Radiol; 2023 Sep 01; 52(6):20230119. PubMed ID: 37395742
    [Abstract] [Full Text] [Related]

  • 15. Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Watanabe S, Nakajima K, Mizokami A, Yaegashi H, Noguchi N, Kawashiri S, Inokuchi M, Kinuya S.
    Ann Nucl Med; 2017 Apr 01; 31(3):201-210. PubMed ID: 27995542
    [Abstract] [Full Text] [Related]

  • 16. Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).
    Baba A, Ojiri H, Goto TK, Ikeda K, Yamauchi H, Ogino N, Mogami T.
    Jpn Dent Sci Rev; 2019 Nov 01; 55(1):58-64. PubMed ID: 30815046
    [Abstract] [Full Text] [Related]

  • 17. Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.
    Tohashi K, Nakabayashi M, Kodani I, Kidani K, Ryoke K.
    Yonago Acta Med; 2016 Mar 01; 59(1):45-53. PubMed ID: 27046950
    [Abstract] [Full Text] [Related]

  • 18. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Minami Y, Ogura I.
    J Med Imaging Radiat Oncol; 2021 Apr 01; 65(2):160-165. PubMed ID: 33180378
    [Abstract] [Full Text] [Related]

  • 19. Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.
    Watanabe T, Yoshida T, Akizuki S, Yamanaka S, Nakao K, Fukuhara S, Asai K, Uozumi R, Bessho K.
    J Bone Miner Metab; 2022 Jul 01; 40(4):657-662. PubMed ID: 35534635
    [Abstract] [Full Text] [Related]

  • 20. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
    Ogawa R, Ogura I.
    Dentomaxillofac Radiol; 2021 Dec 01; 50(8):20200516. PubMed ID: 34019434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.